Thus, our study suggests that DEPTOR inhibits the tumorigenesis of ESCC cells and might serve as a potential therapeutic target or prognostic marker for human patients with esophageal squamous cell carcinoma. This evidence concerns the gene DEPTOR and esophageal squamous cell carcinoma.